WO2022241852A1 - Preparation method for bioactive substance coated polyester mesh layer scaffold - Google Patents
Preparation method for bioactive substance coated polyester mesh layer scaffold Download PDFInfo
- Publication number
- WO2022241852A1 WO2022241852A1 PCT/CN2021/097993 CN2021097993W WO2022241852A1 WO 2022241852 A1 WO2022241852 A1 WO 2022241852A1 CN 2021097993 W CN2021097993 W CN 2021097993W WO 2022241852 A1 WO2022241852 A1 WO 2022241852A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mesh sheet
- solution
- biologically active
- collagen
- preparation
- Prior art date
Links
- 229920000728 polyester Polymers 0.000 title claims abstract description 62
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 22
- 239000000126 substance Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 53
- 238000000576 coating method Methods 0.000 claims abstract description 51
- 239000011248 coating agent Substances 0.000 claims abstract description 50
- 230000008878 coupling Effects 0.000 claims abstract description 29
- 238000010168 coupling process Methods 0.000 claims abstract description 28
- 238000005859 coupling reaction Methods 0.000 claims abstract description 28
- 238000004132 cross linking Methods 0.000 claims abstract description 18
- 230000004913 activation Effects 0.000 claims abstract description 16
- 239000012670 alkaline solution Substances 0.000 claims abstract description 12
- 238000011282 treatment Methods 0.000 claims abstract description 9
- 230000021523 carboxylation Effects 0.000 claims abstract description 7
- 238000006473 carboxylation reaction Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 5
- 230000000903 blocking effect Effects 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 46
- 102000008186 Collagen Human genes 0.000 claims description 35
- 108010035532 Collagen Proteins 0.000 claims description 35
- 229920001436 collagen Polymers 0.000 claims description 35
- 229940088623 biologically active substance Drugs 0.000 claims description 21
- 239000011159 matrix material Substances 0.000 claims description 15
- 239000011149 active material Substances 0.000 claims description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- LLLVZDVNHNWSDS-UHFFFAOYSA-N 4-methylidene-3,5-dioxabicyclo[5.2.2]undeca-1(9),7,10-triene-2,6-dione Chemical compound C1(C2=CC=C(C(=O)OC(=C)O1)C=C2)=O LLLVZDVNHNWSDS-UHFFFAOYSA-N 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- -1 polybutylene terephthalate Polymers 0.000 claims description 8
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- 102000012422 Collagen Type I Human genes 0.000 claims description 4
- 108010022452 Collagen Type I Proteins 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 229960003964 deoxycholic acid Drugs 0.000 claims description 3
- 125000004185 ester group Chemical group 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 3
- 229920001610 polycaprolactone Polymers 0.000 claims description 3
- 239000004632 polycaprolactone Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 1
- NMYFVWYGKGVPIW-UHFFFAOYSA-N 3,7-dioxabicyclo[7.2.2]trideca-1(11),9,12-triene-2,8-dione Chemical compound O=C1OCCCOC(=O)C2=CC=C1C=C2 NMYFVWYGKGVPIW-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000005520 cutting process Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 claims 1
- 238000004506 ultrasonic cleaning Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000002787 reinforcement Effects 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 37
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 22
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 22
- 210000002744 extracellular matrix Anatomy 0.000 description 22
- 230000003592 biomimetic effect Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 239000013543 active substance Substances 0.000 description 10
- 238000004113 cell culture Methods 0.000 description 8
- 239000002861 polymer material Substances 0.000 description 8
- 238000007789 sealing Methods 0.000 description 7
- 102000001187 Collagen Type III Human genes 0.000 description 6
- 108010069502 Collagen Type III Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 230000005714 functional activity Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- SFHBJXIEBWOOFA-UHFFFAOYSA-N 5-methyl-3,6-dioxabicyclo[6.2.2]dodeca-1(10),8,11-triene-2,7-dione Chemical compound O=C1OC(C)COC(=O)C2=CC=C1C=C2 SFHBJXIEBWOOFA-UHFFFAOYSA-N 0.000 description 2
- 102000000503 Collagen Type II Human genes 0.000 description 2
- 108010041390 Collagen Type II Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000003954 umbilical cord Anatomy 0.000 description 2
- IKCQWKJZLSDDSS-UHFFFAOYSA-N 2-formyloxyethyl formate Chemical compound O=COCCOC=O IKCQWKJZLSDDSS-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000670727 Amida Species 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000007825 activation reagent Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Definitions
- the present application relates to the technical field of tissue engineering, in particular to a method for preparing a biologically active substance-coated polyester mesh sheet scaffold.
- a bioreactor is a bioreactor for large-scale production of cells or for large-scale production of cells or for harvesting cell culture products.
- anchorage-dependent cells mainly add scaffold materials to the reactor to provide a cell growth surface, and realize high-density cell culture through the high specific surface area of the material.
- Cytodex microcarriers mainly include Cytodex microcarriers, Cytopore microcarriers, and fibrous scaffolds.
- the Cytodex microcarrier as a cell surface attachment matrix is a spherical two-dimensional cell culture material.
- the cells naturally settle on the surface of the microcarrier under the action of gravity, and the shape changes from spherical to flat.
- the cells will undergo dedifferentiation, so that the cultured cells gradually lose many physiological characteristics of their source tissues.
- large-scale production of cells can be achieved, it is difficult to effectively maintain the activity and function of cells.
- this mode of cell outsourcing material the liquid shear force of the reactor will damage the viability and function of the cells.
- Cytopore microcarrier is a kind of porous microcarrier. Cells grow in the pores of the material, which can realize three-dimensional culture and reduce the damage to cells caused by shear force.
- the reactor culture mode based on Cytopore microcarriers is stirring type. Although this porous structure can reduce the damage of shear force to cells to a certain extent, it cannot fundamentally eliminate the influence of shear force on cells.
- Fibrous scaffolds such as Fibra Disk carriers have a certain mechanical strength and good mechanical properties, and can realize the three-dimensional culture structure of cells in vitro. However, the biocompatibility of pure polymer materials is still certain compared with natural extracellular matrix components. Defects.
- the purpose of this application is to provide a biologically active substance-coated polyester mesh sheet that combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials
- the method of preparation of the scaffold is to provide a biologically active substance-coated polyester mesh sheet that combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials
- a method for preparing a biologically active substance-coated polyester mesh sheet stent comprising the following steps:
- the polyester material is spunbonded and reinforced into a mesh sheet
- the coated mesh sheet is sealed to obtain the biologically active substance-coated polyester mesh sheet support.
- the polyester material is spunbonded and processed into a mesh sheet, and the mesh sheet is carboxylated, Activation of the four steps of cross-linking, coupling and sealing to achieve the coating, by adjusting the parameters to realize the covalent connection between the biomimetic extracellular matrix and the synthetic polymer polyester material, without special equipment such as plasma surface treatment machine, and also does not introduce Toxic chemicals ensure the safety and quality of biological products.
- the bioactive substance-coated polyester mesh sheet scaffold made combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials, providing a good support for cell culture.
- the biomimetic culture environment promotes the adhesion, growth and proliferation of cells in the reactor and the maintenance of functional activities.
- the polyester sheet scaffold after coating has higher porosity and specific surface area, which is conducive to mass transfer and can meet the requirements of high-quality cells during production. , high density, and long-term functional maintenance requirements, it can become an ideal loading material for cells in perfusion (packed) bed/stent reactors.
- Fig. 1 is the process flow chart of the preparation method of the biologically active substance-coated polyester mesh sheet stent of the present application
- Fig. 2 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material without biologically active substance coating
- Fig. 3 is the XPS analysis result of the ethylene terephthalate mesh sheet support material after collagen coating
- Fig. 4 is the FTIR spectrogram of the mesh sheet scaffold material before and after the biological active material coating
- Fig. 5 is the measurement structure of the specific surface area of the mesh sheet scaffold material before and after the coating of biologically active substances
- Fig. 6 is the measurement result of the porosity of the reticular sheet scaffold material before and after the biological active material coating
- Fig. 7 is the image observed under the scanning electron microscope of the C3A hepatocytes cultured on the mesh sheet scaffold material after coating on the 7th day;
- Fig. 8 is the image observed under the scanning electron microscope of the mesenchymal stem cells cultured on the mesh sheet scaffold material after coating on the 7th day;
- Fig. 9 is an ELISA detection image of the difference in the expression of functional activity of C3A hepatocytes after being cultured with the mesh sheet scaffold material before and after coating.
- This application relates to a bionic extracellular matrix bioactive substance-coated polyester mesh sheet scaffold, which uses bionic extracellular matrix components to construct a microenvironment that simulates the growth of cells in vivo, has good structural stability and mechanical properties, and is suitable for Large-scale three-dimensional culture of adherent cells in vitro can realize large-scale cell culture and promote cell biological activity and function maintenance.
- coated polyester mesh sheet scaffold includes a mesh sheet and biological tissue covering the surface of the mesh sheet.
- Active material coating, the mesh sheet is made of polyester material, and the surface of the mesh sheet can be coupled multiple times after carboxylation to form a biologically active substance coating, and at the same time A sealing layer is also provided outside the active material coating.
- the polyester material forming the mesh sheet includes polycaprolactone, polyester carbonate, ethylene terephthalate, polybutylene terephthalate, propylene terephthalate, polyethylene A combination of one or more of terephthalate-1,4-cyclohexanedimethylester fiber and polyethylene-2,6-naphthalene, and the above-mentioned polyethylene
- a net-like sheet made of ester material the thickness of the net-like sheet is 100-500 ⁇ m, and the diameter of a single net-like fiber of the net-like sheet is 25-35 ⁇ m, and the porosity is between 45% and 85%.
- the mesh sheet of the present application has good flexibility and plasticity, which is convenient to take and shape, so that the mesh sheet can be designed into a shape of any size, and the material can be enlarged by folding into a certain angle.
- the stacking area in the reactor is convenient for subsequent coating treatment, and the growth area of cells can be increased in a limited space to achieve high-density culture of cells.
- the mesh sheet needs to undergo carboxylation treatment and activation crosslinking treatment before coating.
- the cleaned mesh sheet can be soaked in a strong alkaline solution, so that the ester group of the polyester material is broken to expose carboxyl group, and then soak the carboxylated mesh sheet into MES solution (0.1mol MES+0.5mol sodium chloride, pH 4.7 ⁇ 6.0) for activation, and then add EDC and NHS to the MES in proportion solution to further activate and crosslink, and the final concentration of the EDC is 2 to 5mmol/ml, the ratio of EDC and NHS can be 1:2 to 1:9, through the above steps of activation and crosslinking, can adjust the The carboxyl group of the above-mentioned network sheet is activated to an active state, and at the same time, the strength of the subsequent connection of the carboxyl group is enhanced, so as to realize the combination of bionic extracellular matrix bioactive substances and polyester synthetic polymer materials by activating and cross-linking the network sheet. covalently linked, and then a coating of biologically active
- the biologically active substance coating is formed by sequentially coupling a collagen solution, a mixed solution containing collagen and hyaluronic acid, and an acellular matrix solution, wherein the pH of the collagen solution is 7.2 to 7.5, and the concentration is 3-12 mg/ml, and the collagen in the collagen solution is one or more than one of type I, type II, and type III collagen, for example, type I collagen and type III collagen are mixed and both The ratio is 3:1 to 1:3; the mixed solution contains the above-mentioned collagen and 10 mg/ml hyaluronic acid with a concentration of 3 to 12 mg/ml, and the pH of the mixed solution is also 7.2 to 7.5;
- the acellular matrix solution is made from animal-derived liver, kidney, heart or umbilical cord, etc., by trimming animal organs and tissues into small pieces, and stirring them with a solution containing 0.01% to 0.04% trypsin and 0.03% to 0.07% EDTA for 1 ⁇ 4h, then soaked and stirred in 2%
- the net-like sheet is coated three times, and the collagen in the collagen solution, the mixed solution, and the acellular matrix solution and the carboxyl group on the surface of the net-like sheet can be formed on the surface of the net-like sheet.
- the grid structure containing three different active substances enables the polyester mesh sheet of the application to obtain higher porosity and specific surface area, and can also meet the high quality, high density and long-term functional maintenance of cells during production requirements, the coated polyester mesh sheet scaffold of the present application has good biocompatibility, which is conducive to cell adhesion, promotion of cell differentiation and proliferation, and maintenance of cell function.
- the mesh sheet needs to undergo carboxylation treatment before coating.
- the cleaned mesh sheet can be soaked in MES solution (0.1mol MES+0.5mol sodium chloride, pH 4.7-6.0) Activation in MES solution, and then add EDC and NHS in proportion to the MES solution for further activation and crosslinking, and the final concentration of EDC is 2-5mmol/ml, the ratio of EDC and NHS can be 1:2 ⁇ 1:9.
- Described network sheet layer can form sealing layer on its surface by adding at least one in 20mmol/ml lysine, arginine or glycine after coating, and described sealing layer utilizes lysine, arginine and Amino acid molecules such as glycine seize the position of the group where the coating can undergo chemical reactions, thereby inactivating the activity of the coating, avoiding the consumption of the coating, and prolonging the life of the coating.
- the biomimetic extracellular matrix biologically active material-coated polyester mesh sheet scaffold of the present application simulates the physiological environment of the cell body to construct a three-dimensional culture system by coating the bionic extracellular matrix on the mesh sheet, so that the constructed The physiological environment is close to the actual physiological environment of the cell body.
- the reticular sheet has been coupled three times, that is, three different active substances are covalently connected to the reticular sheet through carboxyl groups, specifically including type I and type II active substances.
- biomimetic extracellular matrix bioactive substances can support and connect tissue structures, regulate the occurrence of tissues and the physiological activities of cells, and can affect all life phenomena such as cell morphology, proliferation, function, survival, differentiation, and migration.
- the mesh sheet can provide support for the coating of the biomimetic extracellular matrix bioactive substance constructed externally, so that the biomimetic extracellular matrix bioactive substance coating polyester mesh sheet scaffold of the present application has good Structural stability and mechanical properties, with good mechanical properties, can realize three-dimensional culture of cells in vitro.
- the biomimetic extracellular matrix bioactive material-coated polyester mesh sheet scaffold of the present application combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials.
- the scaffold of this application not only has a certain mechanical strength and good biocompatibility, but also provides a bionic culture environment for cell culture, promotes the adhesion, growth and proliferation of cells in the reactor, and maintains functional activity.
- the ester sheet scaffold has higher porosity and specific surface area, which is conducive to mass transfer and can meet the requirements of high-quality, high-density, and long-term functional maintenance of cells during production, and can become an ideal for perfusion (packed) bed/stent reactor cells Load material.
- This application also relates to a preparation method of a polyester mesh sheet scaffold coated with bioactive substances, specifically the preparation method of the above-mentioned biomimetic extracellular matrix bioactive substance coated polyester mesh sheet scaffold, please refer to Figure 1, Specifically include the following steps:
- polyester material is spunbonded and reinforced into a mesh sheet.
- the polyester material in this embodiment includes polycaprolactone, polyester carbonate, ethylene terephthalate, polybutylene terephthalate, propylene terephthalate, polyethylene
- One or more combinations of terephthalate-1,4-cyclohexanedimethylester fiber and polyethylene-2,6-naphthalene diester, the above-mentioned polyester materials are processed by spunbonding and reinforcement Means made of mesh sheet.
- the thickness of the mesh sheet made in this embodiment is 100-500 ⁇ m, the porosity is between 45% and 85%, and the diameter of a single mesh fiber is 25-35 ⁇ m.
- the mesh sheet of this embodiment has A certain degree of softness and plasticity facilitates easy handling, shaping and stacking in the reactor during subsequent processing.
- the present application can design the shaped net-like sheet into any size shape, and can also be folded into a certain angle to increase the stacking area of the net-like sheet in the reactor.
- the strong alkaline solution solute in this embodiment is at least one of sodium hydroxide, potassium hydroxide, and lithium hydroxide, and the strong alkaline solution contains solute % to 20% in mass volume percentage .
- the MES solution of this embodiment includes 0.1 mol/L of 2-(N-morpholino)ethanesulfonic acid and 0.5 mol/L of sodium chloride, and the pH of the MES is adjusted to 4.6-6.0 .
- EDC 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
- NHS N-hydroxysuccinimide
- the final concentration of EDC in the MES is 2-5mmol/ml, and the ratio of EDC to NHS is in the range of 1:2-1:9, so as to perform secondary activation on the mesh sheet and cross-linking, the reaction time is 15 minutes to 3 hours, so as to activate the carboxyl group of the mesh sheet to an optimal state, so as to facilitate coupling with the biomimetic extracellular matrix.
- the activation and cross-linking reaction can be terminated by adding 2-mercaptoethanol into the MES solution, so as to proceed to the next step.
- the bioactive substance coating is formed on the mesh sheet by coupling the mesh sheet three times, which is specifically divided into three stages:
- a collagen solution which contains collagen at a concentration of 3-12 mg/ml, and the collagen is one or more than one of collagen types I, II, and III, for example, I
- the ratio of type collagen: type III collagen is 3:1-1:1, and the pH value of the collagen solution is adjusted to 7.2-7.5.
- the activated mesh sheet into the collagen solution and perform a coupling with the collagen once, the coupling time is 30min-4h, then the collagen can be covalently linked to the carboxyl group through its amino group to coupled to the mesh sheet.
- a secondary coupling treatment is performed on the network sheet.
- a mixed solution containing collagen at a concentration of 3-12 mg/ml and glycosaminoglycans at a concentration of 10-80 mg/ml is prepared.
- the glycosaminoglycans in this embodiment are preferably hyaluronic acid, and the collagen and the above-mentioned
- the collagen in the primary coupling stage is the same, and the pH value of the mixed solution is adjusted to 7.2-7.5.
- the decellularized matrix solution required for the third coupling is configured.
- the decellularized tissue solution is a solution that removes cellular components from tissues or organs by physical, chemical, enzymatic and other methods, and retains the structure and components of the extracellular matrix.
- the extracellular matrix is a complex secreted by cells of tissues and organs, which is a complex of structural and functional proteins, including type I collagen, type III collagen, fibronectin, laminin, and glycosamine Glycans and various cell growth factors, etc., can form an acellular matrix gel coating on the mesh sheet through three couplings of the decellularized tissue solution.
- the decellularized tissue solution of the present application is prepared using animal-derived organ tissues as tissue materials, such as liver, kidney, heart or umbilical cord, etc., first cut the animal-derived organ tissues into small pieces, and use 0.01% to 0.04 % trypsin and 0.03% to 0.07% ethylenediaminetetraacetic acid (EDTA) solution (EDTA) were stirred for 1 to 4 hours, and then soaked and stirred in 2% to 5% polyethylene glycol octylphenyl ether solution (TritonX-100) for 1 to 4 hours.
- animal-derived organ tissues as tissue materials, such as liver, kidney, heart or umbilical cord, etc.
- the net-like sheet after coating is sealed by adding at least one of 20-50 mmol/ml of lysine, arginine or glycine, so as to protect the coating of the net-like sheet, After the sealing is completed, the biomimetic extracellular matrix bioactive substance-coated polyester mesh sheet scaffold of the present application can be obtained.
- biomimetic extracellular matrix bioactive material-coated polyester mesh sheet scaffold can be sterilized by electron beam radiation of 10-20 kGy, and then stored at 4°C.
- the preparation method of the biologically active substance-coated polyester mesh sheet scaffold of the present application is to spunbond the polyester material, process it into a mesh sheet, and carry out carboxylation and activation crosslinking on the mesh sheet , Coupling and sealing four steps to achieve the coating, by adjusting the parameters to realize the covalent connection between the biomimetic extracellular matrix and the synthetic polymer polyester material, no special equipment such as plasma surface treatment machine is required, and no toxic chemicals are introduced , to ensure the safety and quality of the production of biological products.
- bionic extracellular matrix biologically active material-coated polyester mesh sheet scaffold for cell culture of the present application was tested and used for animal cell culture experiments.
- Ethylene glycol diformate network sheet as an example, the results show:
- X-ray photoelectron spectroscopy (XPS) analysis and Fourier transform infrared (FTIR) analysis were performed on the ethylene terephthalate network sheet scaffold material coated with biomimetic extracellular matrix bioactive substances, respectively as shown in Figure 1 ⁇ Figure 5 results.
- Fig. 2 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material not coated with biologically active substances, and the material is mainly composed of C elements and O elements.
- Figure 3 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material coated with collagen type I collagen: type III collagen at a ratio of 3:1, and N elements appear in the main parts of the material.
- Figure 4 is the FTIR spectrum of the mesh sheet scaffold material before and after coating with biologically active substances. Curve A represents uncoated, and curve B represents after coating. There are obvious differences between the two. Curve B is at 1550cm -1 and 1665cm - The characteristic absorption peaks of collagen (AmidII, AmidI and AmidA) appeared near 1 and 3330cm -1 , which further suggested that the bioactive substance had been covalently linked to the material.
- Figure 5 and Figure 6 are the specific surface area and porosity measurement results of the mesh sheet scaffold material before and after coating with biologically active substances, wherein A is uncoated, B represents after coating, and the mesh sheet scaffold can be seen after coating The specific surface area and porosity of the material are significantly improved.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
A preparation method for a bioactive substance coated polyester mesh layer scaffold, which comprises the following steps: forming a mesh layer from a polyester material by means of spun bonding and reinforcement; washing and drying the mesh layer; utilizing a strong alkaline solution to perform carboxylation treatment on the washed and dried mesh layer; performing activation and crosslinking on the mesh layer; performing repeated coupling on the mesh layer to form a bioactive substance coating on the mesh layer; performing blocking on the coated mesh layer, and obtaining a bioactive substance coated polyester mesh layer scaffold.
Description
本申请涉及组织工程技术领域,尤其涉及一种生物活性物质覆层聚酯网状片层支架的制备方法。The present application relates to the technical field of tissue engineering, in particular to a method for preparing a biologically active substance-coated polyester mesh sheet scaffold.
细胞增殖、分化和代谢等生理活动都严重受到微环境的调控影响,生物反应器是以规模化生产细胞或以规模化生产细胞或以收获细胞培养产物为目的的一种生物反应装置。其中,贴壁依赖性细胞主要在反应器中加入支架材料以提供细胞生长表面,通过材料的高比表面积,实现细胞的高密度培养。Physiological activities such as cell proliferation, differentiation, and metabolism are seriously affected by the regulation of the microenvironment. A bioreactor is a bioreactor for large-scale production of cells or for large-scale production of cells or for harvesting cell culture products. Among them, anchorage-dependent cells mainly add scaffold materials to the reactor to provide a cell growth surface, and realize high-density cell culture through the high specific surface area of the material.
目前,常用的生物反应器内支架材料主要包括Cytodex微载体、Cytopore微载体、纤维状支架等。作为细胞表面贴附基质的Cytodex微载体是一种球形的细胞二维培养材料,细胞受到重力的作用而自然沉降在微载体表面,形态由球状变为扁平状。这种培养模式下细胞会发生去分化现象,使培养的细胞逐渐失去其来源组织的许多生理特征。虽然可以实现细胞的规模化生产,但是细胞的活性和功能难以有效维持。同时这种细胞外包材料的模式,反应器的液态剪切力会对细胞的活率及功能有所损害。Cytopore微载体是一种多孔式微载体,细胞生长于材料的多孔内,可以实现三维培养并降低剪切力对细胞的损伤。基于Cytopore微载体的反应器培养模式为搅拌式,虽然这种多孔结构可以在一定程度上降低剪切力对细胞的损伤,但是并不能从根本上消除剪切力对细胞的影响。纤维状支架如Fibra Disk载体具备一定的机械强度,有良好的力学性能,可以实现细胞的体外三维培养结构,但是,单纯高分子材料,其生物相容性与天然细胞外基质成分比较仍有一定的缺陷。At present, commonly used scaffold materials in bioreactors mainly include Cytodex microcarriers, Cytopore microcarriers, and fibrous scaffolds. The Cytodex microcarrier as a cell surface attachment matrix is a spherical two-dimensional cell culture material. The cells naturally settle on the surface of the microcarrier under the action of gravity, and the shape changes from spherical to flat. In this culture mode, the cells will undergo dedifferentiation, so that the cultured cells gradually lose many physiological characteristics of their source tissues. Although large-scale production of cells can be achieved, it is difficult to effectively maintain the activity and function of cells. At the same time, in this mode of cell outsourcing material, the liquid shear force of the reactor will damage the viability and function of the cells. Cytopore microcarrier is a kind of porous microcarrier. Cells grow in the pores of the material, which can realize three-dimensional culture and reduce the damage to cells caused by shear force. The reactor culture mode based on Cytopore microcarriers is stirring type. Although this porous structure can reduce the damage of shear force to cells to a certain extent, it cannot fundamentally eliminate the influence of shear force on cells. Fibrous scaffolds such as Fibra Disk carriers have a certain mechanical strength and good mechanical properties, and can realize the three-dimensional culture structure of cells in vitro. However, the biocompatibility of pure polymer materials is still certain compared with natural extracellular matrix components. Defects.
发明内容Contents of the invention
本申请的目的旨在提供一种将合成聚酯高分子材料具备一定的机械性能、可塑性的优势与天然高分子材料良好的生物相容性相结合的生物活性物质覆层聚酯网状片层支架的制备方法,The purpose of this application is to provide a biologically active substance-coated polyester mesh sheet that combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials The method of preparation of the scaffold,
为了实现上述目的,本申请提供以下技术方案:In order to achieve the above object, the application provides the following technical solutions:
一种生物活性物质覆层聚酯网状片层支架的制备方法,包括以下步骤:A method for preparing a biologically active substance-coated polyester mesh sheet stent, comprising the following steps:
将聚酯材料通过纺粘、加固为网状片层;The polyester material is spunbonded and reinforced into a mesh sheet;
对所述网状片层进行清洗和干燥;Cleaning and drying the mesh sheet;
利用强碱性溶液对清洗干燥完毕的网状片层进行羧基化处理;Using a strong alkaline solution to carboxylate the washed and dried mesh sheet;
对所述网状片层进行活化和交联;activating and crosslinking the network sheet;
对所述网状片层进行多次偶联以在网状片层上形成生物活性物质覆层;performing multiple couplings to the mesh sheet to form a biologically active material coating on the mesh sheet;
对覆层后的网状片层进行封闭,得到所述生物活性物质覆层聚酯网状片层支架。The coated mesh sheet is sealed to obtain the biologically active substance-coated polyester mesh sheet support.
相比现有技术,本申请的方案具有以下优点:Compared with the prior art, the scheme of the present application has the following advantages:
在本申请的生物活性物质覆层聚酯网状片层支架的制备方法中,通过对聚酯材料进行纺粘、加工制作成网状片层,并对所述网状片层进行羧基化、活化交联、偶联和封闭四个步骤来实现覆层,通过调整参数来实现仿生细胞外基质与合成高分子聚酯材料的共价连接,无需等离子表面处理机等特殊设备,同时也不引入有毒化学物质,保证生物制品生产的安全质量。并且制成的生物活性物质覆层聚酯网状片层支架将合成聚酯高分子材料具备一定的机械性能、可塑性的优势与天然高分子材料良好的生物相容性相结合,为细胞培养提供仿生的培养环境,促进反应器内细胞的黏附、生长增殖和功能活性维持,同时覆层后聚酯片层支架具有更高的孔隙率和比表面积,利于传质能满足生产时对细胞高质量、高密度、长时间功能维持的要求,能够成为灌注(填充)床/支架反应器细胞理想的装载材料。In the preparation method of the biologically active material-coated polyester mesh sheet stent of the present application, the polyester material is spunbonded and processed into a mesh sheet, and the mesh sheet is carboxylated, Activation of the four steps of cross-linking, coupling and sealing to achieve the coating, by adjusting the parameters to realize the covalent connection between the biomimetic extracellular matrix and the synthetic polymer polyester material, without special equipment such as plasma surface treatment machine, and also does not introduce Toxic chemicals ensure the safety and quality of biological products. And the bioactive substance-coated polyester mesh sheet scaffold made combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials, providing a good support for cell culture. The biomimetic culture environment promotes the adhesion, growth and proliferation of cells in the reactor and the maintenance of functional activities. At the same time, the polyester sheet scaffold after coating has higher porosity and specific surface area, which is conducive to mass transfer and can meet the requirements of high-quality cells during production. , high density, and long-term functional maintenance requirements, it can become an ideal loading material for cells in perfusion (packed) bed/stent reactors.
本申请附加的方面和优点将在下面的描述中部分给出,这些将从下面的描述中变得明显,或通过本申请的实践了解到。Additional aspects and advantages of the application will be set forth in part in the description which follows, and will become apparent from the description, or may be learned by practice of the application.
本申请上述的和/或附加的方面和优点从下面结合附图对实施例的描述中将变得明显和容易理解,其中:The above and/or additional aspects and advantages of the present application will become apparent and easy to understand from the following description of the embodiments in conjunction with the accompanying drawings, wherein:
图1本申请的生物活性物质覆层聚酯网状片层支架的制备方法的工艺流程图;Fig. 1 is the process flow chart of the preparation method of the biologically active substance-coated polyester mesh sheet stent of the present application;
图2为未经生物活性物质覆层的对苯二甲酸乙二醇酯网状片层支架材料的XPS分析结果;Fig. 2 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material without biologically active substance coating;
图3为经胶原蛋白覆层后的对苯二甲酸乙二醇酯网状片层支架材料的XPS分析结果;Fig. 3 is the XPS analysis result of the ethylene terephthalate mesh sheet support material after collagen coating;
图4为生物活性物质覆层前后网状片层支架材料的FTIR谱图;Fig. 4 is the FTIR spectrogram of the mesh sheet scaffold material before and after the biological active material coating;
图5为生物活性物质覆层前后网状片层支架材料的比表面积的测定结构;Fig. 5 is the measurement structure of the specific surface area of the mesh sheet scaffold material before and after the coating of biologically active substances;
图6为生物活性物质覆层前后网状片层支架材料的孔隙率测定结果;Fig. 6 is the measurement result of the porosity of the reticular sheet scaffold material before and after the biological active material coating;
图7为覆层后的网状片层支架材料培养的C3A肝细胞在第7天时扫描电镜下观察到的图像;Fig. 7 is the image observed under the scanning electron microscope of the C3A hepatocytes cultured on the mesh sheet scaffold material after coating on the 7th day;
图8为覆层后的网状片层支架材料培养的间充质干细胞在第7天时扫描电镜下观察到的图像;Fig. 8 is the image observed under the scanning electron microscope of the mesenchymal stem cells cultured on the mesh sheet scaffold material after coating on the 7th day;
图9为C3A肝细胞经覆层前后网状片层支架材料培养后功能活性表达的差异的ELISA检测图像。Fig. 9 is an ELISA detection image of the difference in the expression of functional activity of C3A hepatocytes after being cultured with the mesh sheet scaffold material before and after coating.
下面详细描述本申请的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,仅用于解释本申请,而不能解释为对本申请的限制。Embodiments of the present application are described in detail below, examples of which are shown in the drawings, wherein the same or similar reference numerals denote the same or similar elements or elements having the same or similar functions throughout. The embodiments described below by referring to the figures are exemplary only for explaining the present application, and are not construed as limiting the present application.
本申请涉及一种仿生细胞外基质生物活性物质覆层聚酯网状片层支架,其通过仿生细胞外基质成分来构建模拟细胞体内生长微环境,具有良好的结构稳定性和机械性能,适于贴壁细胞体外的大规模三维培养,能够 实现细胞规模化培养并促进细胞生物活性和功能维持。This application relates to a bionic extracellular matrix bioactive substance-coated polyester mesh sheet scaffold, which uses bionic extracellular matrix components to construct a microenvironment that simulates the growth of cells in vivo, has good structural stability and mechanical properties, and is suitable for Large-scale three-dimensional culture of adherent cells in vitro can realize large-scale cell culture and promote cell biological activity and function maintenance.
所述仿生细胞外基质生物活性物质覆层聚酯网状片层支架(以下简称“覆层聚酯网状片层支架”)包括网状片层及覆盖在所述网状片层表面的生物活性物质覆层,所述网状片层采用聚酯材料制成,且所述网状片层的表面经羧基化后可经过多次偶联以形成生物活性物质覆层,同时在所述生物活性物质覆层外还设有封闭层。The biomimetic extracellular matrix biologically active material-coated polyester mesh sheet scaffold (hereinafter referred to as "coated polyester mesh sheet scaffold") includes a mesh sheet and biological tissue covering the surface of the mesh sheet. Active material coating, the mesh sheet is made of polyester material, and the surface of the mesh sheet can be coupled multiple times after carboxylation to form a biologically active substance coating, and at the same time A sealing layer is also provided outside the active material coating.
具体地,形成网状片层的聚酯材料包括聚己内酯、碳酸聚酯、对苯二甲酸乙二醇酯、聚对苯二甲酸丁二酯、局对苯二甲酸丙二酯、聚对苯二甲酸-1,4-环己二甲酯纤维及聚-2,6-萘二酸乙二酯中的一种或多种的组合物,并通过纺粘、加固等手段将上述聚酯材料制成网状片层,该网状片层的厚度为100~500μm,且该网状片层的单根网状纤维的直径为25~35μm,孔隙率在45%~85%之间,使得本申请的网状片层具有良好的柔性和可塑性,方便拿取、塑形,从而可将所述网状片层设计成任意大小的形状,并可通过折叠成一定角度来增大材料在反应器内的堆叠面积,以便于后续的覆层处理,可在有限的空间内增大细胞的生长面积,实现细胞的高密度培养。Specifically, the polyester material forming the mesh sheet includes polycaprolactone, polyester carbonate, ethylene terephthalate, polybutylene terephthalate, propylene terephthalate, polyethylene A combination of one or more of terephthalate-1,4-cyclohexanedimethylester fiber and polyethylene-2,6-naphthalene, and the above-mentioned polyethylene A net-like sheet made of ester material, the thickness of the net-like sheet is 100-500 μm, and the diameter of a single net-like fiber of the net-like sheet is 25-35 μm, and the porosity is between 45% and 85%. , so that the mesh sheet of the present application has good flexibility and plasticity, which is convenient to take and shape, so that the mesh sheet can be designed into a shape of any size, and the material can be enlarged by folding into a certain angle. The stacking area in the reactor is convenient for subsequent coating treatment, and the growth area of cells can be increased in a limited space to achieve high-density culture of cells.
所述网状片层在进行覆层前需经过羧基化处理和活化交联处理,具体可将清洗好的网状片层浸泡在强碱性溶液中,使得聚酯材料的酯基断裂以暴露羧基,然后再将羧基化后的网状片层浸泡入MES溶液(0.1molMES+0.5mol氯化钠,pH为4.7~6.0)中进行活化,然后在将EDC和NHS按比例加入到所述MES溶液中以进一步活化和交联,且所述EDC的最终浓度为2~5mmol/ml,EDC和NHS的比例可为1:2~1:9,通过上述活化和交联的步骤,可调节所述网状片层的羧基至活泼状态,同时增强羧基后续联结的强度,以通过对所述网状片层进行活化和交联来实现仿生细胞外基质生物活性物质与聚酯合成高分子材料的共价连接,继而在所述网状片层上形成生物活性物质覆层。The mesh sheet needs to undergo carboxylation treatment and activation crosslinking treatment before coating. Specifically, the cleaned mesh sheet can be soaked in a strong alkaline solution, so that the ester group of the polyester material is broken to expose carboxyl group, and then soak the carboxylated mesh sheet into MES solution (0.1mol MES+0.5mol sodium chloride, pH 4.7~6.0) for activation, and then add EDC and NHS to the MES in proportion solution to further activate and crosslink, and the final concentration of the EDC is 2 to 5mmol/ml, the ratio of EDC and NHS can be 1:2 to 1:9, through the above steps of activation and crosslinking, can adjust the The carboxyl group of the above-mentioned network sheet is activated to an active state, and at the same time, the strength of the subsequent connection of the carboxyl group is enhanced, so as to realize the combination of bionic extracellular matrix bioactive substances and polyester synthetic polymer materials by activating and cross-linking the network sheet. covalently linked, and then a coating of biologically active substances is formed on the mesh sheet.
所述生物活性物质覆层为依次经过胶原蛋白溶液、含有胶原蛋白与透明质酸的混合溶液及脱细胞基质溶液偶联而成,其中,所述胶原蛋白溶液的pH为7.2~7.5,浓度为3~12mg/ml,且所述胶原蛋白溶液中的胶原蛋白为Ⅰ、Ⅱ、Ⅲ型胶原蛋白中的一种或一种以上的混合物,例如,Ⅰ型胶原蛋白和Ⅲ型胶 原蛋白混合且两者的比例为3:1~1:3;所述混合溶液含有浓度为3~12mg/ml的上述胶原蛋白和10mg/ml的透明质酸,且该混合溶液pH亦为7.2~7.5;所述脱细胞基质溶液采用动物来源的肝脏、肾脏、心脏或脐带等制成,具体通过将动物器官组织修剪成小块,用含有0.01%~0.04%胰酶和0.03%~0.07%EDTA溶液搅拌1~4h,然后用2%~5%Triton X-100浸泡搅拌1~4h,接着再浸泡于3%~6%的脱氧胆酸钠溶液中1~4h,从而可得到脱细胞基质支架,再对该脱细胞基质支架进行冷冻干燥并研磨成粉末状,用盐酸胃蛋白酶消化48~96h后,随后可配置成3~12mg/ml的脱细胞基质溶液。所述网状片层经三次偶联覆层,所述胶原蛋白溶液、混合溶液及脱细胞基质溶液中的胶原蛋白与所述网状片层表面羧基联结可在所述网状片层表面形成包含有三种不同活性物质的网架结构,使得本申请的聚酯网状片层能够获得更高的孔隙率和比表面积,还能够满足细胞在生产时的高质量、高密度以及长时间功能维持的要求,使得本申请的覆层聚酯网状片层支架具有良好的生物相容性,有利于细胞黏附、促进细胞分化增值及维持细胞功能。The biologically active substance coating is formed by sequentially coupling a collagen solution, a mixed solution containing collagen and hyaluronic acid, and an acellular matrix solution, wherein the pH of the collagen solution is 7.2 to 7.5, and the concentration is 3-12 mg/ml, and the collagen in the collagen solution is one or more than one of type I, type II, and type III collagen, for example, type I collagen and type III collagen are mixed and both The ratio is 3:1 to 1:3; the mixed solution contains the above-mentioned collagen and 10 mg/ml hyaluronic acid with a concentration of 3 to 12 mg/ml, and the pH of the mixed solution is also 7.2 to 7.5; The acellular matrix solution is made from animal-derived liver, kidney, heart or umbilical cord, etc., by trimming animal organs and tissues into small pieces, and stirring them with a solution containing 0.01% to 0.04% trypsin and 0.03% to 0.07% EDTA for 1~ 4h, then soaked and stirred in 2%-5% Triton X-100 for 1-4h, and then soaked in 3%-6% sodium deoxycholate solution for 1-4h, so as to obtain the acellular matrix scaffold, and then the The acellular matrix scaffold is freeze-dried and ground into a powder, digested with pepsin hydrochloride for 48-96 hours, and then can be formulated into a 3-12 mg/ml acellular matrix solution. The net-like sheet is coated three times, and the collagen in the collagen solution, the mixed solution, and the acellular matrix solution and the carboxyl group on the surface of the net-like sheet can be formed on the surface of the net-like sheet. The grid structure containing three different active substances enables the polyester mesh sheet of the application to obtain higher porosity and specific surface area, and can also meet the high quality, high density and long-term functional maintenance of cells during production requirements, the coated polyester mesh sheet scaffold of the present application has good biocompatibility, which is conducive to cell adhesion, promotion of cell differentiation and proliferation, and maintenance of cell function.
此外,所述网状片层在进行覆层前需经过羧基化处理,具体可将经过清洗后的网状片层浸泡入MES溶液(0.1molMES+0.5mol氯化钠,pH为4.7~6.0)中进行活化,然后在将EDC和NHS按比例加入到所述MES溶液中以进一步活化和交联,且所述EDC的最终浓度为2~5mmol/ml,EDC和NHS的比例可为1:2~1:9。In addition, the mesh sheet needs to undergo carboxylation treatment before coating. Specifically, the cleaned mesh sheet can be soaked in MES solution (0.1mol MES+0.5mol sodium chloride, pH 4.7-6.0) Activation in MES solution, and then add EDC and NHS in proportion to the MES solution for further activation and crosslinking, and the final concentration of EDC is 2-5mmol/ml, the ratio of EDC and NHS can be 1:2 ~1:9.
所述网状片层在覆层后可通过加入20mmol/ml赖氨酸、精氨酸或甘氨酸中至少一种以在其表面形成封闭层,所述封闭层利用赖氨酸、精氨酸及甘氨酸等氨基酸分子抢占覆层可以发生化学反应的基团位置,从而钝化所述覆层的活性,避免所述覆层的消耗,延长所述覆层的寿命。Described network sheet layer can form sealing layer on its surface by adding at least one in 20mmol/ml lysine, arginine or glycine after coating, and described sealing layer utilizes lysine, arginine and Amino acid molecules such as glycine seize the position of the group where the coating can undergo chemical reactions, thereby inactivating the activity of the coating, avoiding the consumption of the coating, and prolonging the life of the coating.
本申请的仿生细胞外基质生物活性物质覆层聚酯网状片层支架通过在网状片层上进行仿生细胞外基质覆层来模拟细胞机体体内的生理环境构建三维培养体系,使得所构建的生理环境接近于细胞机体实际的生理环境,所述网状片层经过三次偶联,即在所述网状片层通过羧基共价连接三种不同的活性物质,具体包括由Ⅰ型、Ⅱ型、Ⅲ型胶原、纤维联结蛋白等蛋白以及透明质酸和硫酸乙酰肝素等糖胺聚糖以及多种细胞生长因子,以 在所述网状片层外构成仿生细胞外基质生物活性物质的覆层,能够支持并连接组织结构、调节组织的发生和细胞的生理活动,可以影响细胞的形态、增殖、功能、存活、分化、迁移等一切生命现象。通过将细胞培植在本申请构建的仿生细胞外基质生物活性物质的网架结构中,利用该覆层充当细胞的生长支架,使得细胞能够分化产生一定的三维特异性结构,最大程度地模拟体内状态。同时,所述网状片层可为其外部构建的仿生细胞外基质生物活性物质的覆层提供支撑,使得本申请的仿生细胞外基质生物活性物质覆层聚酯网状片层支架具有良好的结构稳定性和机械性能,具有良好的力学性能,可以实现细胞的体外三维培养。The biomimetic extracellular matrix biologically active material-coated polyester mesh sheet scaffold of the present application simulates the physiological environment of the cell body to construct a three-dimensional culture system by coating the bionic extracellular matrix on the mesh sheet, so that the constructed The physiological environment is close to the actual physiological environment of the cell body. The reticular sheet has been coupled three times, that is, three different active substances are covalently connected to the reticular sheet through carboxyl groups, specifically including type I and type II active substances. , type III collagen, fibronectin and other proteins, glycosaminoglycans such as hyaluronic acid and heparan sulfate, and various cell growth factors, so as to form a coating of biomimetic extracellular matrix bioactive substances outside the mesh sheet , can support and connect tissue structures, regulate the occurrence of tissues and the physiological activities of cells, and can affect all life phenomena such as cell morphology, proliferation, function, survival, differentiation, and migration. By cultivating cells in the grid structure of biomimetic extracellular matrix bioactive substances constructed in this application, using the coating as a growth scaffold for cells, cells can differentiate to produce a certain three-dimensional specific structure, simulating the state of the body to the greatest extent . At the same time, the mesh sheet can provide support for the coating of the biomimetic extracellular matrix bioactive substance constructed externally, so that the biomimetic extracellular matrix bioactive substance coating polyester mesh sheet scaffold of the present application has good Structural stability and mechanical properties, with good mechanical properties, can realize three-dimensional culture of cells in vitro.
综上,本申请的仿生细胞外基质生物活性物质覆层聚酯网状片层支架将合成聚酯高分子材料具备一定的机械性能、可塑性的优势与天然高分子材料良好的生物相容性相结合,使得本申请的支架不仅具有一定的机械强度和良好的生物相容性,为细胞培养提供仿生的培养环境,促进反应器内细胞的黏附、生长增殖和功能活性维持,同时覆层后聚酯片层支架具有更高的孔隙率和比表面积,利于传质能满足生产时对细胞高质量、高密度、长时间功能维持的要求,能够成为灌注(填充)床/支架反应器细胞理想的装载材料。In summary, the biomimetic extracellular matrix bioactive material-coated polyester mesh sheet scaffold of the present application combines the advantages of synthetic polyester polymer materials with certain mechanical properties and plasticity with the good biocompatibility of natural polymer materials. Combined, the scaffold of this application not only has a certain mechanical strength and good biocompatibility, but also provides a bionic culture environment for cell culture, promotes the adhesion, growth and proliferation of cells in the reactor, and maintains functional activity. The ester sheet scaffold has higher porosity and specific surface area, which is conducive to mass transfer and can meet the requirements of high-quality, high-density, and long-term functional maintenance of cells during production, and can become an ideal for perfusion (packed) bed/stent reactor cells Load material.
本申请还涉及一种生物活性物质覆层聚酯网状片层支架的制备方法,具体为上述仿生细胞外基质生物活性物质覆层聚酯网状片层支架的制备方法,请结合图1,具体包括以下步骤:This application also relates to a preparation method of a polyester mesh sheet scaffold coated with bioactive substances, specifically the preparation method of the above-mentioned biomimetic extracellular matrix bioactive substance coated polyester mesh sheet scaffold, please refer to Figure 1, Specifically include the following steps:
(1)将聚酯材料通过纺粘、加固为网状片层。(1) The polyester material is spunbonded and reinforced into a mesh sheet.
优选地,本实施例中的聚酯材料包括包括聚己内酯、碳酸聚酯、对苯二甲酸乙二醇酯、聚对苯二甲酸丁二酯、局对苯二甲酸丙二酯、聚对苯二甲酸-1,4-环己二甲酯纤维及聚-2,6-萘二酸乙二酯中的一种或多种组合物,将上述聚酯材料通过纺粘、加固的加工手段制成网状片层。本实施例所制成的网状片层的厚度为100~500μm,孔隙率在45%~85%之间,单根网状纤维的直径为25~35μm,本实施例的网状片层具备一定的柔和型和可塑性,便于在后续加工中方便拿取、塑形和在反应器内堆叠。本申请可将成型的网状片层设计成任意大小的形状,还可折叠成一定角 度来增大网状片层在反应器内的堆叠面积。Preferably, the polyester material in this embodiment includes polycaprolactone, polyester carbonate, ethylene terephthalate, polybutylene terephthalate, propylene terephthalate, polyethylene One or more combinations of terephthalate-1,4-cyclohexanedimethylester fiber and polyethylene-2,6-naphthalene diester, the above-mentioned polyester materials are processed by spunbonding and reinforcement Means made of mesh sheet. The thickness of the mesh sheet made in this embodiment is 100-500 μm, the porosity is between 45% and 85%, and the diameter of a single mesh fiber is 25-35 μm. The mesh sheet of this embodiment has A certain degree of softness and plasticity facilitates easy handling, shaping and stacking in the reactor during subsequent processing. The present application can design the shaped net-like sheet into any size shape, and can also be folded into a certain angle to increase the stacking area of the net-like sheet in the reactor.
(2)对所述网状片层进行清洗和干燥。(2) Washing and drying the mesh sheet.
将上述网状片层分别用乙醇、丙酮和超纯水各清洗8~15min,以除去所述网状片层表面的有机杂质和水溶性杂质,再在40℃~80℃下干燥过夜。Wash the above-mentioned mesh sheet with ethanol, acetone and ultrapure water for 8-15 minutes respectively to remove organic impurities and water-soluble impurities on the surface of the mesh sheet, and then dry overnight at 40°C-80°C.
(3)利用强碱性溶液对清洗干燥完毕的网状片层进行羧基化处理。(3) Using a strong alkaline solution to carry out carboxylation treatment on the washed and dried mesh sheet.
将上述清洗、干燥后的网状片层浸泡在强碱性溶液中20~50min,以断裂聚酯网状片层的酯基而暴露羧基。Soak the washed and dried mesh sheet in a strong alkaline solution for 20-50 minutes to break the ester group of the polyester mesh sheet and expose the carboxyl group.
优选地,本实施例中的强碱性溶液溶质为氢氧化钠、氢氧化钾、氢氧化锂中的至少一种,且该强碱性溶液包含有以质量体积百分比计的溶质%~20%。Preferably, the strong alkaline solution solute in this embodiment is at least one of sodium hydroxide, potassium hydroxide, and lithium hydroxide, and the strong alkaline solution contains solute % to 20% in mass volume percentage .
(4)对所述网状片层进行活化和交联。(4) Activating and cross-linking the network sheet.
首先,将上述羧基化处理后的网状片层浸泡在2-(N-吗啉代)乙磺酸(简称“MES”)溶液中进行一次活化,活化时间为30min~4h。优选地,本实施例的MES溶液中包括0.1mol/L的2-(N-吗啉代)乙磺酸和0.5mol/L的氯化钠,并将所述MES的pH调至4.6~6.0。First, soak the above-mentioned carboxylated network sheet in 2-(N-morpholino)ethanesulfonic acid ("MES" for short) solution for one activation, and the activation time is 30 minutes to 4 hours. Preferably, the MES solution of this embodiment includes 0.1 mol/L of 2-(N-morpholino)ethanesulfonic acid and 0.5 mol/L of sodium chloride, and the pH of the MES is adjusted to 4.6-6.0 .
随后,将1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(简称EDC,为可溶于水的碳二亚胺)和N-羟基琥珀酰亚胺(简称“NHS”)按比例加入到上述MES溶液中,其中,EDC常用作羧基的活化试剂以及活化磷酸酯基团、蛋白质与核酸的交联,NHS常用于生物偶联和交联,通过联用EDC和NHS可有效地促进偶联效率。优选地,EDC在所述MES中的最终浓度为2~5mmol//ml,且EDC和NHS的比例范围在1:2~1:9之间,从而对所述网状片层进行二次活化和交联,反应时间为15min~3h,以将所述网状片层的羧基活化至最佳状态,便于与仿生细胞外基质进行偶联。Subsequently, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (abbreviated as EDC, a water-soluble carbodiimide) and N-hydroxysuccinimide ( "NHS" for short) is added in proportion to the above MES solution, among which, EDC is often used as an activation reagent for carboxyl groups and activated phosphate groups, cross-linking of proteins and nucleic acids, and NHS is often used for biological coupling and cross-linking. EDC and NHS can effectively promote coupling efficiency. Preferably, the final concentration of EDC in the MES is 2-5mmol/ml, and the ratio of EDC to NHS is in the range of 1:2-1:9, so as to perform secondary activation on the mesh sheet and cross-linking, the reaction time is 15 minutes to 3 hours, so as to activate the carboxyl group of the mesh sheet to an optimal state, so as to facilitate coupling with the biomimetic extracellular matrix.
此外,上述的二次活化及交联的过程中,通过在所述MES溶液中加入2-巯基乙醇即可终止活化及交联反应,以进行下一个步骤。In addition, during the above-mentioned secondary activation and cross-linking process, the activation and cross-linking reaction can be terminated by adding 2-mercaptoethanol into the MES solution, so as to proceed to the next step.
(5)对所述网状片层进行多次偶联以在网状片层上形成生物活性物质覆层。(5) Coupling the mesh sheet multiple times to form a biologically active material coating on the mesh sheet.
在本实施例中,通过对所述网状片层进行三次偶联在所述网状片层上形成生物活性物质覆层,具体分为三个阶段:In this embodiment, the bioactive substance coating is formed on the mesh sheet by coupling the mesh sheet three times, which is specifically divided into three stages:
首先,配置胶原蛋白溶液,该胶原蛋白溶液含有浓度为3~12mg/ml的胶原蛋白,且所述胶原蛋白为Ⅰ、Ⅱ、Ⅲ型胶原蛋白中的一种或一种以上的混合物,例如Ⅰ型胶原蛋白:Ⅲ型胶原蛋白的比例为3:1~1:1,同时将所述胶原蛋白溶液的pH值调节至7.2~7.5。将活化后的网状片层投入到所述胶原蛋白溶液中与所述胶原蛋白进行一次偶联,偶联时间为30min~4h,即可将所述胶原蛋白通过其氨基与羧基共价连接以偶联到所述网状片层上。First, configure a collagen solution, which contains collagen at a concentration of 3-12 mg/ml, and the collagen is one or more than one of collagen types I, II, and III, for example, I The ratio of type collagen: type III collagen is 3:1-1:1, and the pH value of the collagen solution is adjusted to 7.2-7.5. Put the activated mesh sheet into the collagen solution and perform a coupling with the collagen once, the coupling time is 30min-4h, then the collagen can be covalently linked to the carboxyl group through its amino group to coupled to the mesh sheet.
随后,对所述网状片层进行二次偶联处理。具体地,配置含有浓度为3~12mg/ml的胶原蛋白和10~80mg/ml糖胺聚糖的混合溶液,本实施例中的糖胺聚糖优选采用透明质酸,所述胶原蛋白与上述一次偶联阶段中的胶原蛋白相同,并将所述混合溶液的pH值调节至7.2~7.5。将上述一次偶联后的网状片层投入到所述混合溶液中以与所述胶原蛋白和所述糖胺聚糖进行二次偶联,偶联时间为30min~4h,即可将所述胶原蛋白和糖胺聚糖偶联到所述网状片层上。Subsequently, a secondary coupling treatment is performed on the network sheet. Specifically, a mixed solution containing collagen at a concentration of 3-12 mg/ml and glycosaminoglycans at a concentration of 10-80 mg/ml is prepared. The glycosaminoglycans in this embodiment are preferably hyaluronic acid, and the collagen and the above-mentioned The collagen in the primary coupling stage is the same, and the pH value of the mixed solution is adjusted to 7.2-7.5. Put the above-mentioned reticular sheets after the primary coupling into the mixed solution to perform secondary coupling with the collagen and the glycosaminoglycan, and the coupling time is 30 minutes to 4 hours, then the Collagen and glycosaminoglycans are coupled to the network sheet.
最后,对所述网状片层进行三次偶联处理。具体地,配置三次偶联所需的脱细胞基质溶液,所述脱细胞组织溶液是采用物理、化学、酶解等方法对组织或器官去除细胞成分,保留细胞外基质的结构和成分的溶液,细胞外基质是组织和器官的细胞分泌到胞外的复合物,其是结构蛋白和功能蛋白的复合体,包含有Ⅰ型胶原蛋白、Ⅲ型胶原蛋白、纤维联结蛋白、层粘连蛋白、糖胺聚糖和多种细胞生长因子等,则通过脱细胞组织溶液的三次偶联可在所述网状片层上形成脱细胞基质凝胶覆层。Finally, three coupling treatments are performed on the mesh sheet. Specifically, the decellularized matrix solution required for the third coupling is configured. The decellularized tissue solution is a solution that removes cellular components from tissues or organs by physical, chemical, enzymatic and other methods, and retains the structure and components of the extracellular matrix. The extracellular matrix is a complex secreted by cells of tissues and organs, which is a complex of structural and functional proteins, including type I collagen, type III collagen, fibronectin, laminin, and glycosamine Glycans and various cell growth factors, etc., can form an acellular matrix gel coating on the mesh sheet through three couplings of the decellularized tissue solution.
优选地,本申请的脱细胞组织溶液采用动物来源的器官组织作为组织材料来制备,例如肝脏、肾脏、心脏或脐带等,先将动物来源的器官组织剪成小块,用含有0.01%~0.04%胰酶和0.03%~0.07%乙二胺四乙酸溶液(EDTA)搅拌1~4h,再用2%~5%的聚乙二醇辛基苯基醚溶液(TritonX-100)浸泡搅拌1~4h,接着再浸泡于3%~6%的脱氧胆酸钠溶液中1~4h,将浸泡结束后的脱细胞的小块支架冷冻干燥并研磨成粉末,再用盐酸胃蛋白酶消化48h~96h后,即可配置成3~12mg/ml的脱细胞基质溶液。将上述二次偶联后的网状片 层放入到所述脱细胞基质溶液中以与其胶原蛋白进行偶联,偶联时间为30min~4h。Preferably, the decellularized tissue solution of the present application is prepared using animal-derived organ tissues as tissue materials, such as liver, kidney, heart or umbilical cord, etc., first cut the animal-derived organ tissues into small pieces, and use 0.01% to 0.04 % trypsin and 0.03% to 0.07% ethylenediaminetetraacetic acid (EDTA) solution (EDTA) were stirred for 1 to 4 hours, and then soaked and stirred in 2% to 5% polyethylene glycol octylphenyl ether solution (TritonX-100) for 1 to 4 hours. 4h, then soak in 3%-6% sodium deoxycholate solution for 1-4h, freeze-dry the small decellularized scaffolds after soaking and grind them into powder, and then digest them with pepsin hydrochloride for 48h-96h , can be configured into 3 ~ 12mg/ml acellular matrix solution. The above-mentioned reticular sheets after secondary coupling are put into the decellularized matrix solution to couple with collagen, and the coupling time is 30min-4h.
经过上述三个阶段的不同溶液的偶联,可在所述网状片层上形成三种不同材料的覆层,每种覆层的活性物质不同,并具有不同的功能。Through the coupling of different solutions in the above three stages, coatings of three different materials can be formed on the mesh sheet, each coating has different active substances and has different functions.
(6)对覆层后的网状片层进行封闭,得到所述生物活性物质覆层聚酯网状片层支架。(6) Sealing the coated mesh sheet to obtain the biologically active substance-coated polyester mesh sheet scaffold.
对覆层后的网状片层通过加入20~50mmol/ml的赖氨酸、精氨酸或甘氨酸中至少一种进行封闭,以对所述网状片层的覆层起到保护的作用,封闭完成后即可获得本申请的仿生细胞外基质生物活性物质覆层聚酯网状片层支架。The net-like sheet after coating is sealed by adding at least one of 20-50 mmol/ml of lysine, arginine or glycine, so as to protect the coating of the net-like sheet, After the sealing is completed, the biomimetic extracellular matrix bioactive substance-coated polyester mesh sheet scaffold of the present application can be obtained.
最后,可将获得的仿生细胞外基质生物活性物质覆层聚酯网状片层支架进行10~20kGy电子束辐射灭菌处理后,于4℃下进行保存。Finally, the obtained biomimetic extracellular matrix bioactive material-coated polyester mesh sheet scaffold can be sterilized by electron beam radiation of 10-20 kGy, and then stored at 4°C.
本申请的生物活性物质覆层聚酯网状片层支架的制备方法通过对聚酯材料进行纺粘、加工制作成网状片层,并对所述网状片层进行羧基化、活化交联、偶联和封闭四个步骤来实现覆层,通过调整参数来实现仿生细胞外基质与合成高分子聚酯材料的共价连接,无需等离子表面处理机等特殊设备,同时也不引入有毒化学物质,保证了生物制品生产的安全质量。The preparation method of the biologically active substance-coated polyester mesh sheet scaffold of the present application is to spunbond the polyester material, process it into a mesh sheet, and carry out carboxylation and activation crosslinking on the mesh sheet , Coupling and sealing four steps to achieve the coating, by adjusting the parameters to realize the covalent connection between the biomimetic extracellular matrix and the synthetic polymer polyester material, no special equipment such as plasma surface treatment machine is required, and no toxic chemicals are introduced , to ensure the safety and quality of the production of biological products.
此外,将本申请细胞培养用仿生细胞外基质生物活性物质覆层聚酯网状片层支架进行相关测试,并将其用于动物细胞培养试验,本申请的聚酯网状片层以对苯二甲酸乙二醇酯网状片层为示例,结果显示:In addition, the bionic extracellular matrix biologically active material-coated polyester mesh sheet scaffold for cell culture of the present application was tested and used for animal cell culture experiments. Ethylene glycol diformate network sheet as an example, the results show:
将仿生细胞外基质生物活性物质覆层的对苯二甲酸乙二醇酯网状片层支架材料进行X射线光电子能谱(XPS)分析和傅里叶红外(FTIR)分析,分别得到如图1~图5结果。其中,图2为未经生物活性物质覆层的对苯二甲酸乙二醇酯网状片层支架材料的XPS分析结果,材料主要由C元素和O元素组成。图3为经Ⅰ型胶原蛋白:Ⅲ型胶原蛋白为3:1的胶原蛋白覆层后的对苯二甲酸乙二醇酯网状片层支架材料的XPS分析结果,N元素出现在材料的主要成分中,提示生物活性物质与材料已实现共价连接。图4为生物活性物质覆层前后网状片层支架材料的FTIR谱图,A曲线代表未覆层,B曲线代表覆层后,两者有明显的差异,B曲线在1550cm
-1、1665cm
-1和3330cm
-1附近均 出现胶原蛋白的特征吸收峰(AmidⅡ、AmidⅠ和AmidA),进一步提示生物活性物质与材料已实现共价连接。图5和图6分别为生物活性物质覆层前后网状片层支架材料的比表面积和孔隙率测定结果,其中A为未覆层,B代表覆层后,可见覆层后网状片层支架材料的比表面积和孔隙率显著提高。
X-ray photoelectron spectroscopy (XPS) analysis and Fourier transform infrared (FTIR) analysis were performed on the ethylene terephthalate network sheet scaffold material coated with biomimetic extracellular matrix bioactive substances, respectively as shown in Figure 1 ~ Figure 5 results. Among them, Fig. 2 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material not coated with biologically active substances, and the material is mainly composed of C elements and O elements. Figure 3 is the XPS analysis result of the ethylene terephthalate mesh sheet scaffold material coated with collagen type I collagen: type III collagen at a ratio of 3:1, and N elements appear in the main parts of the material. In the composition, it is suggested that the biologically active substance has been covalently linked to the material. Figure 4 is the FTIR spectrum of the mesh sheet scaffold material before and after coating with biologically active substances. Curve A represents uncoated, and curve B represents after coating. There are obvious differences between the two. Curve B is at 1550cm -1 and 1665cm - The characteristic absorption peaks of collagen (AmidⅡ, AmidⅠ and AmidA) appeared near 1 and 3330cm -1 , which further suggested that the bioactive substance had been covalently linked to the material. Figure 5 and Figure 6 are the specific surface area and porosity measurement results of the mesh sheet scaffold material before and after coating with biologically active substances, wherein A is uncoated, B represents after coating, and the mesh sheet scaffold can be seen after coating The specific surface area and porosity of the material are significantly improved.
再将生物活性物质覆层前后的材料填充入在先构建的循环灌注式细胞培养系统及其生物反应器(ZL201510738480.6)进行肝细胞和间充质干细胞规模化培养,图7和图8分别显示覆层后的网状片层支架材料培养C3A肝细胞和间充质干细胞第7天时在扫描电镜下观察到的图像,可见大量细胞生长并紧密贴附在材料上,细胞与细胞之间连接紧密,部分细胞呈现出类组织聚团生长的征象。进一步评价C3A肝细胞经胶原蛋白覆层前后网状片层支架材料培养后功能活性表达的差异,于第1、3和5天分别收集培养基上清,进行ELISA检测,结果如图9所示,其中A为未覆层,B代表覆层后,结果显示细胞在覆层后的网状片层支架材料白蛋白分泌量显著高于未覆层的网状片层支架材料,覆层后的网状片层支架材料利于促进细胞分化和功能表达。Then fill the materials before and after coating with biologically active substances into the previously constructed circulating perfusion cell culture system and its bioreactor (ZL201510738480.6) for large-scale culture of hepatocytes and mesenchymal stem cells, as shown in Figure 7 and Figure 8 respectively It shows the image observed under the scanning electron microscope on the 7th day of culturing C3A hepatocytes and mesenchymal stem cells on the coated mesh sheet scaffold material. It can be seen that a large number of cells grow and attach tightly to the material, and the connections between cells Compact, some cells showed signs of tissue-like cluster growth. To further evaluate the difference in the expression of functional activity of C3A hepatocytes before and after collagen coating, the culture supernatants were collected on days 1, 3 and 5, and tested by ELISA. The results are shown in Figure 9 , where A is uncoated, and B represents after coating. The results show that the amount of albumin secreted by the cells in the covered mesh sheet scaffold material is significantly higher than that of the uncoated mesh sheet scaffold material. The mesh sheet scaffold material is beneficial to promote cell differentiation and functional expression.
以上所述仅是本申请的部分实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本申请原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本申请的保护范围。The above descriptions are only some implementations of the present application. It should be pointed out that for those of ordinary skill in the art, some improvements and modifications can be made without departing from the principle of the application. These improvements and modifications are also It should be regarded as the protection scope of this application.
Claims (12)
- 一种生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,包括以下步骤:A method for preparing a biologically active substance-coated polyester mesh sheet stent, characterized in that it comprises the following steps:将聚酯材料通过纺粘、加固为网状片层;The polyester material is spunbonded and reinforced into a mesh sheet;对所述网状片层进行清洗和干燥;Cleaning and drying the mesh sheet;利用强碱性溶液对清洗干燥完毕的网状片层进行羧基化处理;Using a strong alkaline solution to carboxylate the washed and dried mesh sheet;对所述网状片层进行活化和交联;activating and crosslinking the network sheet;对所述网状片层进行多次偶联以在网状片层上形成生物活性物质覆层;performing multiple couplings to the mesh sheet to form a biologically active material coating on the mesh sheet;对覆层后的网状片层进行封闭,得到所述生物活性物质覆层聚酯网状片层支架。The coated mesh sheet is sealed to obtain the biologically active substance-coated polyester mesh sheet support.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,所述聚酯材料包括聚己内酯、碳酸聚酯、对苯二甲酸乙二醇酯、聚对苯二甲酸丁二酯、局对苯二甲酸丙二酯、聚对苯二甲酸-1,4-环己二甲酯纤维及聚-2,6-萘二酸乙二酯中的一种或多种组合物,且所形成的网状片层的单根网状纤维直径为25~35μm。The preparation method of bioactive material coating polyester mesh sheet support according to claim 1, is characterized in that, described polyester material comprises polycaprolactone, carbonate polyester, ethylene terephthalate , polybutylene terephthalate, trimethylene terephthalate, poly-1,4-cyclohexanedimethylene terephthalate fiber and polyethylene-2,6-naphthalate One or more compositions, and the diameter of a single mesh fiber of the formed mesh sheet is 25-35 μm.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,对所述网状片层进行清洗和干燥包括以下步骤:分别用乙醇、丙酮和超纯水对所述网状片层进行超声波清洗,清洗时间各8~15min,再在40℃~80℃下干燥过夜。The preparation method of biologically active substance-coated polyester mesh sheet stent according to claim 1, wherein cleaning and drying the mesh sheet comprises the following steps: using ethanol, acetone and ultrapure Ultrasonic cleaning is performed on the net-shaped sheet layer with water, each cleaning time is 8-15 minutes, and then dried at 40° C.-80° C. overnight.
- 根据权利要求3所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,利用强碱性溶液对清洗干燥完毕的所述网状片层进行羧基化处理包括以下步骤:将清洗干燥后的所述网状片层浸泡在强碱性溶液中 20~50min,以断裂所述网状片层的酯基暴露羧基,所述强碱性溶液的溶质为氢氧化钠、氢氧化钾、氢氧化锂中的至少一种,且所述强碱性溶液中含有以质量体积百分比计的溶质5%~20%。The preparation method of the biologically active substance-coated polyester mesh sheet stent according to claim 3, characterized in that, using a strong alkaline solution to carry out carboxylation treatment on the cleaned and dried mesh sheet includes the following steps : soak the cleaned and dried net-like sheet in a strong alkaline solution for 20 to 50 minutes to expose the carboxyl group by breaking the ester group of the described net-like sheet, and the solute of the strong alkaline solution is sodium hydroxide, At least one of potassium hydroxide and lithium hydroxide, and the strong alkaline solution contains 5% to 20% of solute in terms of mass volume percentage.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,对所述网状片层进行活化和交联包括以下步骤:The preparation method of the biologically active substance-coated polyester mesh sheet stent according to claim 1, wherein activating and crosslinking the mesh sheet comprises the following steps:将羧基化处理后的网状片层浸入2-(N-吗啉代)乙磺酸溶液中进行一次活化,反应时间为30min~4h;Immerse the carboxylated network sheet in 2-(N-morpholino)ethanesulfonic acid solution for one activation, and the reaction time is 30min~4h;将1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和N-羟基琥珀酰亚胺按比例加入到2-(N-吗啉代)乙磺酸溶液中进行二次活化和交联,反应时间为15min~3h;Add 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide in proportion to 2-(N-morpholino)ethanesulfonic acid solution Carry out secondary activation and crosslinking, the reaction time is 15min~3h;最后加入2-巯基乙醇来终止上述活化和交联反应。Finally, 2-mercaptoethanol was added to terminate the activation and cross-linking reaction described above.
- 根据权利要求5所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,所述1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐的浓度为2~5mmol/ml,且所述1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和N-羟基琥珀酰亚胺的质量比例范围为1:2~1:9。The preparation method of biologically active substance coating polyester mesh sheet support according to claim 5, is characterized in that, described 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide salt The concentration of acid salt is 2~5mmol/ml, and the mass ratio range of described 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide is 1:2~1:9.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,对所述网状片层进行偶联以在网状片层上形成生物活性物质覆层,包括以下步骤:The preparation method of the biologically active substance-coated polyester mesh sheet stent according to claim 1, wherein the mesh sheet is coupled to form a bioactive substance coating on the mesh sheet , including the following steps:配置胶原蛋白溶液,将所述网状片层投入所述胶原蛋白溶液中进行一次偶联,反应时间为30min~4h;Collagen solution is configured, and the mesh sheet is put into the collagen solution for one coupling, and the reaction time is 30 minutes to 4 hours;配置包含有胶原蛋白和糖胺聚糖的混合溶液,将上述一次偶联后的网状片层投入到所述混合溶液中进行二次偶联,反应时间为30min~4h;Configure a mixed solution containing collagen and glycosaminoglycans, put the above-mentioned mesh sheet after the primary coupling into the mixed solution for secondary coupling, and the reaction time is 30 minutes to 4 hours;配置脱细胞基质溶液,将上述二次偶联后的网状片层投入到所述脱细胞 基质溶液中进行三次偶联,反应时间为30min~4h。The acellular matrix solution is configured, and the above-mentioned reticular sheets after the secondary coupling are dropped into the acellular matrix solution to carry out three couplings, and the reaction time is 30min to 4h.
- 根据权利要求7所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,所述胶原蛋白溶液的pH值为7.2~7.5,其含有浓度3~12mg/ml的胶原蛋白,所述胶原蛋白为Ⅰ、Ⅱ、Ⅲ型胶原蛋白中的一种或一种以上的混合物。The preparation method of biologically active substance-coated polyester mesh sheet scaffold according to claim 7, characterized in that the pH value of the collagen solution is 7.2 to 7.5, and it contains collagen at a concentration of 3 to 12 mg/ml Protein, the collagen is one or a mixture of type I, II, and III collagen.
- 根据权利要求7所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,所述混合溶液的pH值为7.2~7.5,其含有浓度为3~12mg/ml的胶原蛋白和10mg/ml~80mg/ml的透明质酸,所述胶原蛋白为Ⅰ、Ⅱ、Ⅲ型胶原蛋白中的一种或一种以上的混合物。The preparation method of biologically active material-coated polyester mesh sheet scaffold according to claim 7, characterized in that the pH value of the mixed solution is 7.2-7.5, and it contains collagen with a concentration of 3-12 mg/ml Protein and 10mg/ml-80mg/ml hyaluronic acid, the collagen is one or more than one type of collagen I, II, and III.
- 根据权利要求7所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,所述脱细胞基质溶液采用动物来源的器官组织来制备,先将动物来源的器官组织剪成小块,用含有0.01%~0.04%胰酶和0.03%~0.07%乙二胺四乙酸溶液搅拌1~4h,再用2%~5%的聚乙二醇辛基苯基醚溶液浸泡搅拌1~4h,接着再浸泡于3%~6%的脱氧胆酸钠溶液中1~4h,将浸泡结束后的脱细胞的小块支架冷冻干燥并研磨成粉末,再用盐酸胃蛋白酶消化48h~96h后,即可配置成3~12mg/ml的脱细胞基质溶液。The preparation method of biologically active material-coated polyester mesh sheet scaffold according to claim 7, characterized in that, the acellular matrix solution is prepared by using animal-derived organ tissue, and first cutting the animal-derived organ tissue into small pieces, stirred with a solution containing 0.01% to 0.04% trypsin and 0.03% to 0.07% ethylenediaminetetraacetic acid for 1 to 4 hours, and then soaked and stirred in a solution of 2% to 5% polyethylene glycol octylphenyl ether 1 to 4 hours, then soaked in 3% to 6% sodium deoxycholate solution for 1 to 4 hours, freeze-dried the small decellularized scaffolds after soaking and ground them into powder, and then digested with pepsin hydrochloride for 48 hours to After 96 hours, it can be prepared into a decellularized matrix solution of 3-12 mg/ml.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,对覆层后的网状片层通过加入20~50mmol/ml赖氨酸、精氨酸或甘氨酸中至少一种进行封闭。The preparation method of the biologically active substance-coated polyester mesh sheet stent according to claim 1, characterized in that, adding 20 to 50 mmol/ml lysine and arginine to the mesh sheet after coating Or at least one of glycine for blocking.
- 根据权利要求1所述的生物活性物质覆层聚酯网状片层支架的制备方法,其特征在于,获得所述生物活性物质覆层聚酯网状片层支架后,进行辐照灭菌处理后于4℃下保存。The preparation method of the biologically active substance-coated polyester mesh sheet stent according to claim 1, characterized in that, after obtaining the bioactive substance-coated polyester mesh sheet stent, radiation sterilization is carried out Then store at 4°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110547781.6 | 2021-05-19 | ||
CN202110547781.6A CN113318270B (en) | 2021-05-19 | 2021-05-19 | Method for preparing bioactive substance coated polyester mesh lamellar stent |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022241852A1 true WO2022241852A1 (en) | 2022-11-24 |
Family
ID=77416038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/097993 WO2022241852A1 (en) | 2021-05-19 | 2021-06-02 | Preparation method for bioactive substance coated polyester mesh layer scaffold |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113318270B (en) |
WO (1) | WO2022241852A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277737A (en) * | 2011-04-27 | 2011-12-14 | 南昌大学 | Preparation method and application of polycaprolactone/natural high-molecular composite porous scaffold |
CN103006359A (en) * | 2012-12-24 | 2013-04-03 | 汪泱 | Bionic three-dimensional tissue engineering scaffold and preparation method thereof |
CN106567252A (en) * | 2016-10-19 | 2017-04-19 | 南方医科大学珠江医院 | Fiber carrier and preparation method and application thereof |
CN108118023A (en) * | 2016-11-28 | 2018-06-05 | 广东乾晖生物科技有限公司 | Fibrous framework and its preparation method and application |
CN109364297A (en) * | 2018-12-26 | 2019-02-22 | 上海纳米技术及应用国家工程研究中心有限公司 | Biologically active gelatin-polylactic acid micelle medicine carrying coating preparation method and products thereof and application |
US20190144820A1 (en) * | 2016-04-06 | 2019-05-16 | University-Industry Cooperation Group Of Kyung Hee University | Microbeads for cell culture and method of monitoring cell culture using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040063206A1 (en) * | 2002-09-30 | 2004-04-01 | Rowley Jon A. | Programmable scaffold and method for making and using the same |
EP1535952B1 (en) * | 2003-11-28 | 2013-01-16 | Universite Louis Pasteur | Method for preparing crosslinked polyelectrolyte multilayer films |
US9724308B2 (en) * | 2010-09-10 | 2017-08-08 | Fibralign Corporation | Biodegradable multilayer constructs |
-
2021
- 2021-05-19 CN CN202110547781.6A patent/CN113318270B/en active Active
- 2021-06-02 WO PCT/CN2021/097993 patent/WO2022241852A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277737A (en) * | 2011-04-27 | 2011-12-14 | 南昌大学 | Preparation method and application of polycaprolactone/natural high-molecular composite porous scaffold |
CN103006359A (en) * | 2012-12-24 | 2013-04-03 | 汪泱 | Bionic three-dimensional tissue engineering scaffold and preparation method thereof |
US20190144820A1 (en) * | 2016-04-06 | 2019-05-16 | University-Industry Cooperation Group Of Kyung Hee University | Microbeads for cell culture and method of monitoring cell culture using the same |
CN106567252A (en) * | 2016-10-19 | 2017-04-19 | 南方医科大学珠江医院 | Fiber carrier and preparation method and application thereof |
CN108118023A (en) * | 2016-11-28 | 2018-06-05 | 广东乾晖生物科技有限公司 | Fibrous framework and its preparation method and application |
CN109364297A (en) * | 2018-12-26 | 2019-02-22 | 上海纳米技术及应用国家工程研究中心有限公司 | Biologically active gelatin-polylactic acid micelle medicine carrying coating preparation method and products thereof and application |
Also Published As
Publication number | Publication date |
---|---|
CN113318270B (en) | 2022-03-08 |
CN113318270A (en) | 2021-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110272860B (en) | Construction method and application of three-dimensional cell culture microenvironment | |
Chen et al. | Culturing of skin fibroblasts in a thin PLGA–collagen hybrid mesh | |
CA2483908C (en) | Vascularization enhanced graft constructs | |
CN105963785B (en) | Acellular matrix material based on adipose-derived stem cell membrane and preparation method thereof | |
Pourfarhangi et al. | Construction of scaffolds composed of acellular cardiac extracellular matrix for myocardial tissue engineering | |
CN107988158B (en) | Three-dimensional tumor model acellular porous scaffold, construction method and application thereof | |
CN105254917B (en) | A method of preparing cell patch using Sodium Alginate Hydrogel Films | |
CN101366979B (en) | Tissue patch and preparation method thereof | |
CN112980001B (en) | Collagen composite hyaluronic acid gel, extracellular matrix bionic material and preparation method | |
CN110302427A (en) | A kind of alginate plural gel timbering material and preparation method thereof constructed based on homogeneous crosslinking and layer-by-layer | |
CN113082295B (en) | Derived scaffold based on skin-derived acellular matrix and construction method thereof | |
Anton-Sales et al. | Bacterial nanocellulose and titania hybrids: cytocompatible and cryopreservable cell carriers | |
Ding et al. | Perfusion seeding of collagen–chitosan sponges for dermal tissue engineering | |
CN113621169B (en) | Preparation method and application of polyethylene glycol terephthalate-lung tissue extracellular matrix-removed composite material | |
CN113929934A (en) | Degradation-resistant gelatin microsphere, artificial liver model, construction method and application thereof | |
WO2022062282A1 (en) | Nanocellulose-based cell growth factor sustained-release anisotropic stent construction method and application | |
WO2022241852A1 (en) | Preparation method for bioactive substance coated polyester mesh layer scaffold | |
Sesli et al. | Decellularization of rat adipose tissue, diaphragm, and heart: a comparison of two decellularization methods | |
Xu et al. | An injectable platform of engineered cartilage gel and gelatin methacrylate to promote cartilage regeneration | |
CN114686421B (en) | Preparation method and application of lung tissue extracellular matrix-free microcarrier | |
CN113430159B (en) | Bionic extracellular matrix bioactive substance coating polyester reticular lamellar scaffold | |
CN101791432B (en) | Method for preparing galactose chitosan/polyester polymer composite stent | |
CN113908336B (en) | Lysozyme phase transition membrane modified cellulose scaffold and preparation method and application thereof | |
JP2628536B2 (en) | Cell culture substrate | |
CN111214703B (en) | iPS-derived myocardial cell composite patch and preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21940302 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21940302 Country of ref document: EP Kind code of ref document: A1 |